Automated Insulin Delivery (AID) systems automatically adjust insulin delivery to help control blood glucose levels, reduce hypoglycemia, and increase time in range. AID systems are often called hybrid closed loop systems and allow for a complete circle of communication between a continuous glucose monitor (CGM) and insulin Pod/pump.
The global Closed-loop Automated Insulin Delivery (AID) System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Closed-loop Automated Insulin Delivery (AID) System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Closed-loop Automated Insulin Delivery (AID) System include Medtronic, Tandem Diabetes Care, Admetsys, Insulet, Defymed, Beta Bionics (iLet), Bigfoot Biomedical, Dexcom, MicroTech Medical (Hangzhou) Co., Ltd., Medtrum, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Closed-loop Automated Insulin Delivery (AID) System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Closed-loop Automated Insulin Delivery (AID) System.
The Closed-loop Automated Insulin Delivery (AID) System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Closed-loop Automated Insulin Delivery (AID) System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Closed-loop Automated Insulin Delivery (AID) System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Medtronic
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd.
Medtrum
Segment by Type
Hybrid Closed Loop Systems
DIY Closed Loop Systems
Segment by Application
Children with Type 1 Diabetes
Adults with Type 1 Diabetes
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Closed-loop Automated Insulin Delivery (AID) System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Closed-loop Automated Insulin Delivery (AID) System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Closed-loop Automated Insulin Delivery (AID) System Market Overview
1.1 Product Definition
1.2 Closed-loop Automated Insulin Delivery (AID) System by Type
1.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Value Comparison by Type (2024-2030)
1.2.2 Hybrid Closed Loop Systems
1.2.3 DIY Closed Loop Systems
1.3 Closed-loop Automated Insulin Delivery (AID) System by Application
1.3.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Value by Application (2024-2030)
1.3.2 Children with Type 1 Diabetes
1.3.3 Adults with Type 1 Diabetes
1.4 Global Closed-loop Automated Insulin Delivery (AID) System Market Size Estimates and Forecasts
1.4.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue 2019-2030
1.4.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales 2019-2030
1.4.3 Global Closed-loop Automated Insulin Delivery (AID) System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Closed-loop Automated Insulin Delivery (AID) System Market Competition by Manufacturers
2.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Closed-loop Automated Insulin Delivery (AID) System Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Closed-loop Automated Insulin Delivery (AID) System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Product Type & Application
2.7 Global Key Manufacturers of Closed-loop Automated Insulin Delivery (AID) System, Date of Enter into This Industry
2.8 Global Closed-loop Automated Insulin Delivery (AID) System Market Competitive Situation and Trends
2.8.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Closed-loop Automated Insulin Delivery (AID) System Players Market Share by Revenue
2.8.3 Global Closed-loop Automated Insulin Delivery (AID) System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Closed-loop Automated Insulin Delivery (AID) System Market Scenario by Region
3.1 Global Closed-loop Automated Insulin Delivery (AID) System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region: 2019-2030
3.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region: 2019-2024
3.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Region: 2025-2030
3.3 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region: 2019-2030
3.3.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region: 2019-2024
3.3.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Region: 2025-2030
3.4 North America Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Country
3.4.1 North America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2030)
3.4.3 North America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Country
3.5.1 Europe Closed-loop Automated Insulin Delivery (AID) System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2030)
3.5.3 Europe Closed-loop Automated Insulin Delivery (AID) System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Region
3.6.1 Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Sales by Region (2019-2030)
3.6.3 Asia Pacific Closed-loop Automated Insulin Delivery (AID) System Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Country
3.7.1 Latin America Closed-loop Automated Insulin Delivery (AID) System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2030)
3.7.3 Latin America Closed-loop Automated Insulin Delivery (AID) System Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Market Facts & Figures by Country
3.8.1 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Closed-loop Automated Insulin Delivery (AID) System Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2030)
4.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2019-2024)
4.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Type (2025-2030)
4.1.3 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Type (2019-2030)
4.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2019-2030)
4.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2019-2024)
4.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Type (2025-2030)
4.2.3 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Type (2019-2030)
4.3 Global Closed-loop Automated Insulin Delivery (AID) System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2030)
5.1.1 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2019-2024)
5.1.2 Global Closed-loop Automated Insulin Delivery (AID) System Sales by Application (2025-2030)
5.1.3 Global Closed-loop Automated Insulin Delivery (AID) System Sales Market Share by Application (2019-2030)
5.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2019-2030)
5.2.1 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2019-2024)
5.2.2 Global Closed-loop Automated Insulin Delivery (AID) System Revenue by Application (2025-2030)
5.2.3 Global Closed-loop Automated Insulin Delivery (AID) System Revenue Market Share by Application (2019-2030)
5.3 Global Closed-loop Automated Insulin Delivery (AID) System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Tandem Diabetes Care
6.2.1 Tandem Diabetes Care Company Information
6.2.2 Tandem Diabetes Care Description and Business Overview
6.2.3 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Tandem Diabetes Care Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.2.5 Tandem Diabetes Care Recent Developments/Updates
6.3 Admetsys
6.3.1 Admetsys Company Information
6.3.2 Admetsys Description and Business Overview
6.3.3 Admetsys Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Admetsys Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.3.5 Admetsys Recent Developments/Updates
6.4 Insulet
6.4.1 Insulet Company Information
6.4.2 Insulet Description and Business Overview
6.4.3 Insulet Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Insulet Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.4.5 Insulet Recent Developments/Updates
6.5 Defymed
6.5.1 Defymed Company Information
6.5.2 Defymed Description and Business Overview
6.5.3 Defymed Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Defymed Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.5.5 Defymed Recent Developments/Updates
6.6 Beta Bionics (iLet)
6.6.1 Beta Bionics (iLet) Company Information
6.6.2 Beta Bionics (iLet) Description and Business Overview
6.6.3 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Beta Bionics (iLet) Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.6.5 Beta Bionics (iLet) Recent Developments/Updates
6.7 Bigfoot Biomedical
6.7.1 Bigfoot Biomedical Company Information
6.7.2 Bigfoot Biomedical Description and Business Overview
6.7.3 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Bigfoot Biomedical Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.7.5 Bigfoot Biomedical Recent Developments/Updates
6.8 Dexcom
6.8.1 Dexcom Company Information
6.8.2 Dexcom Description and Business Overview
6.8.3 Dexcom Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Dexcom Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.8.5 Dexcom Recent Developments/Updates
6.9 MicroTech Medical (Hangzhou) Co., Ltd.
6.9.1 MicroTech Medical (Hangzhou) Co., Ltd. Company Information
6.9.2 MicroTech Medical (Hangzhou) Co., Ltd. Description and Business Overview
6.9.3 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 MicroTech Medical (Hangzhou) Co., Ltd. Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.9.5 MicroTech Medical (Hangzhou) Co., Ltd. Recent Developments/Updates
6.10 Medtrum
6.10.1 Medtrum Company Information
6.10.2 Medtrum Description and Business Overview
6.10.3 Medtrum Closed-loop Automated Insulin Delivery (AID) System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Medtrum Closed-loop Automated Insulin Delivery (AID) System Product Portfolio
6.10.5 Medtrum Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Closed-loop Automated Insulin Delivery (AID) System Industry Chain Analysis
7.2 Closed-loop Automated Insulin Delivery (AID) System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Closed-loop Automated Insulin Delivery (AID) System Production Mode & Process
7.4 Closed-loop Automated Insulin Delivery (AID) System Sales and Marketing
7.4.1 Closed-loop Automated Insulin Delivery (AID) System Sales Channels
7.4.2 Closed-loop Automated Insulin Delivery (AID) System Distributors
7.5 Closed-loop Automated Insulin Delivery (AID) System Customers
8 Closed-loop Automated Insulin Delivery (AID) System Market Dynamics
8.1 Closed-loop Automated Insulin Delivery (AID) System Industry Trends
8.2 Closed-loop Automated Insulin Delivery (AID) System Market Drivers
8.3 Closed-loop Automated Insulin Delivery (AID) System Market Challenges
8.4 Closed-loop Automated Insulin Delivery (AID) System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Medtronic
Tandem Diabetes Care
Admetsys
Insulet
Defymed
Beta Bionics (iLet)
Bigfoot Biomedical
Dexcom
MicroTech Medical (Hangzhou) Co., Ltd.
Medtrum
听
听
*If Applicable.
